Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
The Danish drugmaker Lundbeck has appointed Deborah Dunsire, former head of several U.S. firms, including Millennium Pharmaceuticals, as its new CEO. Lundbeck cites Dunsire’s management and research experience as well as her “robust knowledge and experience in neuroscience” as key qualifications. Dunsire, a medical doctor from South Africa, has worked in the U.S. since 1994 and will now move to Denmark. Lundbeck has had an interim CEO since 2017, when Kåre Schultz left to head Teva Pharmaceutical.
This article has been sent to the following recipient: